Is there a genetic basis for resistance to atherosclerosis?

被引:38
作者
Stein, O
Thiery, J
Stein, Y [1 ]
机构
[1] Hadassah Univ Hosp, Div Med, Lipid Res Lab, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Expt Med & Canc Res, IL-91010 Jerusalem, Israel
[3] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany
关键词
scavenger receptors; ABC; LXR; apoprotein E; hypercholesterolemia; macrophages;
D O I
10.1016/S0021-9150(01)00664-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis and its major clinical manifestation. coronary heart disease. is and will remain the main cause of mortality. Reviews on this subject dealt with factors that enhance development of atherosclerosis. This review deals with a new facet, that some individuals are less prone to develop atherosclerosis: (1) despite high cholesterol intake or (2) despite hypercholesterolemia with elevated low-density lipoprotein cholesterol (LDL-C) levels. The variability of response of plasma cholesterol to dietary intake was shown to be regulated by liver x receptor (LXR) that determines the rate of intestinal cholesterol absorption through the ATP-binding cassette (ABC) gene family. Other gene products, Such as apolipoprotein-E (apo-E), scavenger receptor-B1 (SR-B1) and acyl coenzyme: cholesterol acyltransferase-2 (ACAT-2) affect cholesterol absorption also. The role of a genetic background for relative resistance to atherosclerosis is highlighted by subjects with familial hypercholesterolemia in whom high plasma cholesterol levels has not Curtailed their expected life span. Studies in animals have shown that resistance to atherosclerosis in spite of hypercholesterolemia is affected by factors such as high-density lipoprotein (HDL) phospholipids that enhance reverse cholesterol transport, non-responsiveness to induction or lack of monocyte chemotactic protein-1 (MCP-1), C-C chemokine receptor 2 (CCR2), macrophage colony stimulating factor (MCSF), or vascular cell adhesion molecule-1 (VCAM-1). Since macrophages have been regarded as pro- or anti-atherogenic, evidence was collated that the high activity of scavenger receptors may contribute towards resistance to atherosclerosis if accompanied by adequate amounts of apo-E for cholesterol removal. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 110 条
[11]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[12]   TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E-DEFICIENT MICE BY BONE-MARROW TRANSPLANTATION [J].
BOISVERT, WA ;
SPANGENBERG, J ;
CURTISS, LK .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1118-1124
[13]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[14]   The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines [J].
Bortnick, AE ;
Rothblat, GH ;
Stoudt, G ;
Hoppe, KL ;
Royer, LJ ;
McNeish, J ;
Francone, OL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28634-28640
[15]   The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein [J].
Boullier, A ;
Gillotte, KL ;
Hörkkö, S ;
Green, SR ;
Friedmann, P ;
Dennis, EA ;
Witztum, JL ;
Steinberg, D ;
Quehenberger, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) :9163-9169
[16]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[17]   Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice [J].
Buhman, KK ;
Accad, M ;
Novak, S ;
Choi, RS ;
Wong, JS ;
Hamilton, RL ;
Turley, S ;
Farese, RV .
NATURE MEDICINE, 2000, 6 (12) :1341-1347
[18]   CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors [J].
Chinetti, G ;
Gbaguidi, FG ;
Griglio, S ;
Mallat, Z ;
Antonucci, M ;
Poulain, P ;
Chapman, J ;
Fruchart, JC ;
Tedgui, A ;
Najib-Fruchart, J ;
Staels, B .
CIRCULATION, 2000, 101 (20) :2411-2417
[19]   Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice [J].
Collins, AR ;
Meehan, WP ;
Kintscher, U ;
Jackson, S ;
Wakino, S ;
Noh, G ;
Palinski, W ;
Hsueh, WA ;
Law, RE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :365-371
[20]   Genetic background determines the extent of atherosclerosis in ApoE-deficient mice [J].
Dansky, HM ;
Charlton, SA ;
Sikes, JL ;
Heath, SC ;
Simantov, R ;
Levin, LF ;
Shu, P ;
Moore, KJ ;
Breslow, JL ;
Smith, JD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) :1960-1968